Oral glutathione is easily broken down during digestion, leading to lower absorption rates
Importantly, meta-analyses of randomized controlled trials have generally not shown a statistically significant increased risk of pancreatitis with GLP-1 receptor agonists as a class
There are also reports of ustekinumab-induced new-onset vitiligo and alopecia areata
FDA approval of exenatide, its first generic injectable GLP-1 agonist, Amneal (2024) Teva announces FDA approval and launch of generic Saxenda (liraglutide injection) first generic GLP-1 indicated for weight loss, Teva Pharmaceuticals (2025) Exenatide, DailyMed (2025) Byetta, DailyMed (2025) Liraglutide (generic Victoza), DailyMed (2025) Liraglutide (generic Saxenda), DailyMed (2025) Victoza, DailyMed (2025) Saxenda, DailyMed (2025) Compounding and the FDA: Questions and answers, U.S
Regarding androgen production, there was a significant reduction in Leydig cell count, accompanied by a 24.3% drop in serum testosterone